Condition: Neovascular Age-Related Macular Degeneration (nAMD) · Sponsor: 4D Molecular Therapeutics
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
This description comes directly from the study's public registry record.
4DMT Patient Advocacy · (888) 748-8881 · clinicaltrials@4DMT.com
Always discuss trial participation with your own doctor first.
| Research Network Arizona | Scottsdale, Arizona, United States | Recruiting |
| Barnet Dulaney Perkins Eye Center | Sun City, Arizona, United States | Recruiting |
| Retina Associates | Tucson, Arizona, United States | Recruiting |
| Retinal Diagnostic Center | Campbell, California, United States | Recruiting |
| Retina Consultants of Orange County | Fullerton, California, United States | Recruiting |
| Northern California Retina Vitreous Associates | Mountain View, California, United States | Recruiting |
| Retinal Consultants Medical Group Inc. | Sacramento, California, United States | Recruiting |
| Retinal Consultants Medical Group | Sacramento, California, United States | Recruiting |
| West Coast Retina Medical Group | San Francisco, California, United States | Recruiting |
| Bay Area Retina Associates | Walnut Creek, California, United States | Recruiting |
| Retina Consultants of Southern Colorado P.C. | Colorado Springs, Colorado, United States | Recruiting |
| Southwest Retina Consultants | Durango, Colorado, United States | Recruiting |
+ 82 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07064759